BOARD OF DIRECTORS & Executive Committee

---

Eviana Breuss is a MD, PhD molecular biologist with more than 30 years of experience in translational research, with a particular focus on novel therapeutics of highly invasive and angiogenic brain cancers. She obtained her Ph.D. in Clinical Pharmacology and Biochemistry at the Institute of Experimental Cardiology, Cardiovascular Research Center, Moscow, followed by postdoctoral training in molecular and cellular biology at New York Medical College and Columbia University. From 2000 to 2010, Dr. Breuss conducted basic and clinical research at Washington State University, Westchester Medical Center, Columbia University School of Medicine, and NYU School of Medicine, as well as collaborated with  Harvard University, Bristol-Myers Squibb, Cognate Therapeutics, Weill Cornell Presbyterian Medical Center, and Memorial Sloan Kettering Cancer Center, NY. 

Dr. Breuss has extensive experience in designing, developing, and implementing government, DoD, and non-profit organizations grants,  IND, IND amendments, Investigator Brochures, Annual Reports, Health Authority submissions, IRB and IACUC protocols, running preclinical and clinical trials, evaluating emerging bio and nanotechnologies, and establishing lasting academia-industry partnerships. 

Dr. Breuss studied financial planning and corporate law serving at Center of Wealth Preservation and NYL Insurance Company from 2009 to 2012. She is a Founder and President of 501(c)(3) nonprofitable charitable foundation, serving for kids with learning and mental disabilities. 

Dr. Breuss is a Honored Listee of Marques Who's Who of a year 2024, as well as the Member of WorldWide Women's Association, and a member of  The Female Quotient. 

Alexey Breuss, PhD in Clinical Psychology, has extensive experience as a healthcare professional serving pediatric and adolescent patients at the Department of Hematology and Oncology at Weill Cornell New York Presbyterian Hospital and University of Rochester. He obtained his B.S. in Psychology at Stony Brook University in 2015 and master’s degree in School Education Psychology at St. John University in 2018. Dr. Breuss conducted translational research in immunology and cancer therapeutics at Columbia University Medical Center, New York University Medical School, and Weill Cornell New York Presbyterian Hospital. He is proficient in clinical writing as well as specializes in clinical evaluation of clients with mental and learning disabilities and pediatric cancer patients.

  Marat Golnik is the precision mind behind A&L Sheet Metal Inc., a New York–based fabrication company with over two decades of operation across the U.S. and international markets. With more than 40 years of experience in industrial machinery and electronic equipment design, Marat has built a reputation for delivering high-performance enclosures, acoustic frameworks, and structural assemblies that meet the most demanding technical standards. He received his BS in electronic engineering at Belorussian Polytechnic Institute at 1989. 

At A&L, he leads the design and fabrication of custom sheet metal systems for military, aerospace, and advanced manufacturing sectors. His team, certified to ISO 9001:2008 and Premium Quality standards, specializes in small- to medium-scale components that demand structural integrity, electromagnetic shielding, and acoustic control.

Since 2024, Marat has partnered with Avixela to co-develop optomechanical enclosures and reflective system shells for plasma-liquid emitters, nano-resonators, and adaptive acoustic chambers. His contributions enable the physical realization of    

Avixela’s dual-platform architecture—where form, function, and field performance converge. From micro-bent waveguides to multi-layered housings, every component is fabricated to its uncompromising standard.

   Since founding Crystal Glass & Mirror Inc. in 2004, Larry Shvets has led with precision, resilience, and a relentless commitment to material excellence. With a foundation in architectural glass engineering and a legacy of hands-on fabrication, Larry built one of New York’s most trusted custom glass operations—delivering high-load, UV-bonded, and ballistic-grade assemblies for clients demanding zero tolerance for error.

In 2024, Larry joined Avixela to co-develop its dual-platform architecture for advanced coatings and optomechanical integration. His expertise in structural glass, lamination chemistry, and surface bonding now drives the translation of NanoCoat™ hybrid films, angle-sensitive glare suppression, and Dr. Blade deposition techniques into scalable, optically active substrates.

Larry was the first to prototype custom quartz filters for UVC saturation within HVAC DAC systems—engineering antimicrobial glass interfaces coated with functional nanofilms for pathogen-neutralizing performance. His contributions bridge the gap between architectural-grade durability and photonic precision, enabling Avixela’s platforms to deliver both aesthetic resilience and quantum-aligned functionality.

With over 45 years of precision engineering expertise, Yakov Opatzevfky is the founder and driving force behind United Machine Inc., a high-tolerance machining lab based in Paterson, New Jersey. A graduate of Saint Petersburg State University for Water Communications (1974–1979), where he studied marine engineering, Yakov has built one of the East Coast’s most respected facilities for small- to mid-scale component fabrication across military, medical, and industrial sectors.

United Machine Inc. has operated for nearly 25 years in the U.S. and abroad, specializing in parts that demand sub-micron tolerances, non-standard geometries, and extreme material resilience. The shop is ISO 9001, AS9100D, and Premium Quality certified, but it’s Yakov’s personal mastery—his ability to machine dielectric polymers, gold-tungsten alloys, and glass-ceramic hybrids—that sets the standard. Whether it’s a sealed electrode bore or a custom taper others won’t quote, Yakov delivers flawless execution under conditions that shred conventional hardware.

Since 2024, Yakov has partnered with Avixela to co-develop advanced assemblies for plasma-liquid reactors, nano-ignition systems, and UVC isolation chambers. His contributions include injector group bodies with sub-millimeter flow channels calibrated to micropressure tolerances—each bore drilled, reamed, and polished to match spray dynamics under high-frequency pulsing and cavitation. No chatter. No burrs. Just atom-by-atom control. His work is foundational to Avixela’s nano-plasmonic platforms and sovereign manufacturing systems, where durability, precision, and quantum-aligned performance converge.